H.I.G. Capital Completes Acquisition of ITH Group Limited
- Editor
- Jun 9
- 2 min read
Whats Happening:
H.I.G. Capital, a global alternative investment firm with $70 billion in capital under management, has acquired ITH Group Limited, a leading UK provider of aseptic pharmaceutical compounding services. The acquisition was made in partnership with ITH's founders, Adam Bloom and Karen Hamling. ITH specializes in preparing bespoke, injectable medication for patients with specialized medical needs and holds market-leading positions in chemotherapy, total parenteral nutrition, and central intravenous additive services.
Key Moves:
H.I.G. Capital acquires ITH Group Limited, a UK pharmaceutical compounding services provider
Acquisition made in partnership with ITH's founders, Adam Bloom and Karen Hamling
H.I.G. aims to continue ITH's organic growth and support new initiatives, including increasing production capacity
By The Numbers:
H.I.G. Capital has $70 billion of capital under management
H.I.G. has invested in and managed more than 400 companies worldwide
H.I.G.'s current portfolio includes more than 100 companies with combined sales exceeding $53 billion
Key Quotes:
"I'm delighted to welcome H.I.G. as a key investor in the ITH Group," said Adam Bloom, CEO of ITH Group
"We are delighted to be supporting Adam, Karen, and their team to further build upon ITH's success," said John Harper, Managing Director at H.I.G.
"Adam and Karen have built a highly impressive business providing a critical service to the UK health sector," said Gordon Cameron, non-executive Chairman of ITH
Bottom Line:
H.I.G. Capital's acquisition of ITH Group Limited demonstrates the fund's commitment to investing in market-leading healthcare companies. The partnership aims to leverage H.I.G.'s expertise in supporting capacity expansion to drive ITH's growth in the critical aseptic pharmaceutical compounding services sector, potentially improving access to specialized medications for patients in the UK.
Comments